Stratview Research publishes a new report titled Liquid Biopsy Market which is segmented by Products Services Type (Assay Kits, Instruments, and Services), by Application Type (Cancer {Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, and Others} and Non-Cancer), by Clinical Application Type (Therapy Selection, Treatment Monitoring, Recurrence Monitoring, and Early Cancer Screening), by Circulating Biomarkers Type (Circulating Tumor Cells, Cell-Free DNA, Circulating Tumor DNA, Extracellular Vesicles, and Others), by Technology Type (Multi-Gene Parallel Analysis Using NGS and Single-Gene Analysis Using PCR Microarrays), by End-User Type (Reference Laboratories, Hospitals and Physician Laboratories, Academic Research Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).

Market Insights

The liquid biopsy market was valued at US$ 2.4 billion in 2021 and is expected to grow at a CAGR of 18% during 2022-2028 to reach US$ 7.64 billion in 2028.

Global Liquid Biopsy Market Report Segments:

The Liquid Biopsy Market is segmented into the following categories:

By Products Services Type

• Assay Kits
• Instruments
• Services

By Application Type

• Cancer

• Regional Analysis: North America, Europe, Asia-Pacific, and RoW

• Type Analysis: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, and Others

• Non-Cancer

By Clinical Application Type

• Therapy Selection
• Treatment Monitoring
• Recurrence Monitoring
• Early Cancer Screening

By Circulating Biomarkers Type

• Circulating Tumor Cells
• Cell-Free DNA
• Circulating Tumor DNA
• Extracellular Vesicles
• Others

By Technology Type

• Multi-Gene Parallel Analysis Using NGS
• Single-Gene Analysis Using PCR Microarrays

By End-User Type

• Reference Laboratories
• Hospitals and Physician Laboratories
• Academic Research Centers
• Others

By Region

• North America (Country Analysis: the USA, Canada, and Mexico) 
• Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
• Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
• Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

Why is this report beneficial?

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

It also offers –

• Market Overview
• Key Manufacturers Profiles
• Market Analysis by Region
• Market Segment by Type
• Market Segment by Application
• Raw Material and Supply Chain
• Other Key Research Findings

All the data compiled by the market experts is the outcome of rigorous primary and secondary research conducted on the market players and reliable sources, including company white papers, journals, press releases, and more.

Key players active in the market –

The following are some of the key players in the Liquid Biopsy Market:

• Biocept Inc.
• Bio-Rad Laboratories
• F. Hoffmann-La Roche Ltd.
• Guardant Health Inc.
• Illumina, Inc.
• Johnson Johnson
• Laboratory Corporation of America Holdings
• MDxHealth SA
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.

Customization of the report –

At Stratview Research, the market researchers make a note of opportunities, drawbacks/bottlenecks, estimations, and information related to the market using experienced skills and verified methodologies. Our research reports offer an exceptional experience of innovative solutions and outcomes to the users. If required, user can also opt for customization of the report.

Connect with our team at –

Stratview Research

E-mail: sales@stratviewresearvch.com

Direct: +1-313-307-4176